Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis
Experimental Parasitology,
Год журнала:
2025,
Номер
269, С. 108898 - 108898
Опубликована: Янв. 10, 2025
Язык: Английский
Pathway Specific Unbinding Free Energy Profiles of Ritonavir Dissociation from HIV-1 Protease
Biochemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 9, 2025
Investigation
of
protein–drug
recognition
is
key
to
understanding
drug
selectivity
and
binding
affinity.
In
combination,
the
binding/unbinding
free
energy
landscape
intermolecular
interactions
can
be
used
understand
mechanisms.
This
information
vital
for
development
drugs
with
improved
efficacy
explanation
mutation
effects.
study
investigated
dissociation
processes
ritonavir
unbinding
from
HIV
protease
(HIVp).
Analyzing
trajectories
modeled
by
accelerated
molecular
dynamics
(MD)
simulations,
three
distinct
pathways,
pathways
A–C,
were
characterized.
Using
a
reduced
dimensionality
strategy
principal
component
analysis,
we
carried
out
short
classical
MD
runs
explicit
water
sample
local
fluctuation
during
applied
milestoning
theory
construct
an
landscape.
We
found
that
each
pathway
showed
similar
values
energy,
albeit
A
accounts
over
50%
trajectories.
Interestingly,
residue–residue
correlation
network
analysis
in
A,
broad
outside
flap
region
governs
protein
motions
unbinding,
which
includes
residues
reported
However,
other
two
limited
networks
where
no
mutated
involved,
explaining
favorability
A.
Guided
profile,
barrier
minimum,
demonstrating
hydrogen
bonding
governed
movement
regions,
directly
impacting
calculated
energy.
Our
provided
new
estimate
ligand
demonstrated
importance
transient
ligand–protein
unbinding.
Язык: Английский
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Infectious Diseases and Therapy,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 26, 2024
Язык: Английский
COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19
Current Oncology,
Год журнала:
2024,
Номер
31(9), С. 5330 - 5343
Опубликована: Сен. 10, 2024
COVID-19,
a
novel
infectious
disease
caused
by
the
emergence
of
SARS-CoV-2
virus
in
2020,
has
had
profound
impact
on
healthcare,
both
at
individual
and
population
level.
The
level
was
felt
most
acutely
during
emergency
phase
pandemic,
with
hospital
capacity
issues
leading
to
widespread
disruptions
delays
delivery
healthcare
services
such
as
screening
programs
elective
surgeries.
While
hospitals
are
no
longer
being
overwhelmed
COVID-19
patients,
vulnerable
patient
populations
cancer
patients
continues
be
ongoing
consequence.
Cancer
remain
high
risk
hospitalization,
ICU
admission,
death
due
even
era
vaccination.
Infection
prevention
mitigation
strategies
air
quality
control,
masking,
testing,
vaccination,
treatment
should
therefore
integrated
into
usual
care
counseling
moving
forward
avoid
preventable
morbidity
mortality
from
this
infection
ensure
safety
cohort
they
navigate
their
diagnosis
COVID-19.
Язык: Английский
Pathway Specific Unbinding Free Energy Profiles of Ritonavir Dissociation From HIV-1 Protease
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 16, 2024
ABSTRACT
Investigation
of
protein-drug
recognition
is
key
in
understanding
drug
selectivity
and
binding
affinity.
In
combination,
binding/unbinding
free
energy
landscape
intermolecular
interactions
can
be
used
to
understand
the
mechanisms.
This
information
vital
for
development
drugs
with
improved
efficacy
explanation
mutation
effects.
study
investigated
dissociation
processes
ritonavir
unbinding
from
HIV
protease
(HIVp).
Analyzing
trajectories
modeled
by
accelerated
molecular
dynamics
(MD)
simulations,
three
distinct
pathways,
Pathways
A,
B,
C,
were
characterized.
Using
reduced
dimensionality
strategy
principal
component
analysis,
we
carried
out
short
classical
MD
runs
explicit
water
sample
local
fluctuation
during
applied
milestoning
theory
construct
landscape.
We
found
that
each
pathway
showed
similar
values
energy,
albeit
Pathway
A
accounts
over
50
percent
trajectories.
Interesting,
residue-residue
correlation
network
analysis
a
broad
outside
flap
region
governs
protein
motions
which
includes
residues
reported
However,
other
two
pathways
limited
networks
where
no
mutated
involved,
explaining
favorability
A.
Guided
profile,
how
why
an
barrier
minimum
demonstrated
hydrogen
bonding
governed
movement
regions,
directly
impacting
calculated
energy.
Our
provided
new
estimate
ligand
importance
transient
ligand-protein
unbinding.
Язык: Английский